BioCentury
ARTICLE | Company News

SeraCare supply/service news

August 8, 2011 7:00 AM UTC

SeraCare said its board initiated a process to explore and evaluate strategic alternatives, including a sale. Last month, the company disclosed that it had retained Lazard to advise its board but did not provide details. In June, hedge fund MSMB Capital Management LLC made an unsolicited offer to acquire the undisclosed portion of SeraCare it does not already own for $4.25 per share (see BioCentury, July 4). ...